Diabetes Clinical Trials in the United States: A Practical Guide for Patients and Families

Finding the right diabetes clinical trial in the U.S. can feel overwhelming. Between eligibility rules, phase numbers, and unfamiliar medical terms, many people simply give up. But trials across the country are actively recruiting right now, and a little structure goes a long way. This guide walks you through how trials work, where to find them, what to expect financially, and how to decide if participation makes sense for your situation.

Why Trials Matter More Than Ever in 2026

Diabetes research in the U.S. is in a remarkable stretch. The success of GLP-1 medications has opened a wave of follow-on studies, while cell-based therapies for Type 1 diabetes have produced genuine excitement for the first time in decades. At the same time, the registry on ClinicalTrials.gov lists thousands of active diabetes studies spanning every state, from observational surveys to late-stage drug trials.

For people living with diabetes, this activity means options. Some trials focus on people with newly diagnosed Type 1 diabetes, aiming to preserve remaining insulin production. Others recruit people with hard-to-control Type 2 diabetes to test new oral medications. A growing number of studies now use decentralized designs, allowing participants to complete visits from home with remote monitoring devices.

Understanding the Landscape Before You Search

Trials fall into phases, and knowing what each phase means helps you weigh risk against potential benefit. Phase 1 trials test safety in small groups, often with healthy volunteers or closely monitored patients. Phase 2 trials look at dosing and early effectiveness. Phase 3 trials compare the new approach against standard treatment in hundreds or thousands of participants. Phase 4 studies track long-term effects after approval.

A few active or recent studies illustrate the range. The CAPTAIN-T2D trial, run by Sparrow Pharmaceuticals, is testing an investigational drug called clofutriben in people with Type 2 diabetes and elevated cortisol levels, with sites across Arizona, California, and dozens of other locations. Another trial is comparing teplizumab with anti-thymocyte globulin in people at high risk of progressing to Stage 3 Type 1 diabetes, with enrollment at centers including the Barbara Davis Center in Colorado, Yale, and the University of Florida. Vertex Pharmaceuticals' VX-880 program, testing stem cell-derived islet cell transplantation, has shown early participants achieving insulin independence, though this therapy remains in early phases with real unknowns.

The honest framing matters here. A clinical trial is a scientific experiment, not a guaranteed cure. Some studies succeed; many do not. But without volunteers, no new treatment ever reaches the patients who need it.

The Financial Side: Compensation and Coverage

Compensation for diabetes trials varies widely, and understanding the range prevents both disappointment and misplaced expectations. Simple observational studies or online surveys typically pay $25 to $100. Intensive trials requiring frequent clinic visits, overnight stays, or experimental procedures may pay $1,000 to $5,000 or more across the study duration. Payment is designed to reimburse time and travel, not to encourage risky decisions.

Beyond participant compensation, most trials cover study-related procedures, investigational drugs, and lab testing at no cost to participants. Ask specifically about travel reimbursement, lodging for out-of-town visits, and incidental expenses like parking. A legitimate research team will answer these questions openly.

A Quick Look at Trial Types

Trial Category	Example	Typical Format	Best For	Advantages	Challenges
Observational studies	Diet and glucose monitoring surveys	Surveys, wearables, minimal visits	People curious about research	Low risk, flexible	Limited direct treatment benefit
Drug trials (Phase 2-3)	Clofutriben for Type 2 diabetes	Regular clinic visits, 24+ weeks	People open to investigational meds	Access to new therapies, close monitoring	Possible placebo arm, side effects
Immunotherapy trials	Teplizumab for early Type 1	Infusions, frequent monitoring	Relatives of people with Type 1	Potential to delay onset	Strict eligibility, complex protocol
Cell therapy trials	VX-880 stem cell islet transplant	Hospital procedures, long follow-up	People with severe Type 1 complications	Potential insulin independence	Early phase, major unknowns
Decentralized trials	Remote GLP-1 studies	Home visits, telehealth, devices	People with travel constraints	Location flexibility, less time burden	Requires tech access, self-monitoring

Five Steps to Finding and Joining a Trial

Step 1: Use ClinicalTrials.gov as your starting point. This is the official U.S. government registry, maintained by the National Institutes of Health, and it lists every registered trial with an NCT number. Search "Type 1 diabetes" or "Type 2 diabetes" in the condition field, filter by "Recruiting" status, and sort by distance from your zip code. Also filter for "remote" or "virtual" trials if travel is a constraint.

Step 2: Check eligibility criteria carefully before contacting anyone. Every listing includes inclusion and exclusion criteria based on age, diabetes type, disease duration, A1C levels, current medications, and other health conditions. Some trials specifically want people with well-controlled diabetes to test monitoring technology. Others recruit people with difficult-to-control or newly diagnosed diabetes. Read these sections closely, then reach out only if you plausibly fit.

Step 3: Contact the study coordinator with prepared questions. Each listing includes contact information for the research team. Ask what treatment you might receive and the chance of receiving a placebo, known risks and side effects so far, whether you can continue current diabetes medications, what happens if you withdraw, and whether your primary care physician or endocrinologist will be kept informed. A reputable team answers transparently and never pressures you to enroll.

Step 4: Complete informed consent on your own timeline. Before any trial begins, you must sign an Informed Consent Form outlining the study's purpose, risks, benefits, and your rights. Every participant retains the right to withdraw at any time without penalty, the right to receive new safety information as it emerges, and the right to continue standard care if you leave. Bring a family member or patient advocate when reviewing the form. Never sign under pressure.

Step 5: Look beyond the federal registry for specialized support. JDRF, now known as Breakthrough T1D, maintains a trial-matching tool specifically for the Type 1 community. TrialNet offers free screening for relatives of people with Type 1 diabetes to identify early-stage disease and eligibility for prevention studies. University hospital research pages and endocrinology practices in cities like Boston, Houston, and San Francisco often list locally enrolling studies that may not appear in broader searches.

Red Flags to Avoid

Legitimate trials always have a verifiable ClinicalTrials.gov registration number. Be cautious of studies recruited through social media without an NCT number. Be wary of anyone guaranteeing results, promising a cure, or requesting payment to participate. Compensation in legitimate trials reimburses your time and expenses; it never flows in the opposite direction.

Regional Resources Worth Knowing

Research activity clusters in certain regions, though trials operate nationwide. Colorado hosts the Barbara Davis Center, a global hub for Type 1 diabetes prevention research. California has dense networks of clinical research sites, particularly around Los Angeles and the Bay Area, covering everything from GLP-1 studies to cell therapy. Texas and Florida have active metabolic research centers enrolling Type 2 populations. If you live in a rural state, decentralized trials may be your best route, since they reduce travel burden and often provide monitoring devices for home use.

Making the Decision That Fits Your Life

Participation in a clinical trial means close medical supervision, access to cutting-edge monitoring, and compensation for your time. It also means accepting uncertainty. Before you commit, talk with your endocrinologist about how a trial might interact with your current treatment plan. Consider the time commitment honestly, including travel, fasting requirements, and follow-up visits. And remember that saying no is always acceptable; trials need willing volunteers, not reluctant ones.

The diabetes research landscape in the U.S. has never been more active, and the people who shape it are the participants who step forward. Whether you are a family member of someone with Type 1 diabetes looking into prevention screening, a person with Type 2 diabetes curious about investigational medications, or someone who simply wants to contribute data for future patients, there is likely a study that fits your circumstances. Start with the registry, ask good questions, and move at your own pace.